BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 26251241)

  • 1. Cost-Utility Analysis of Mechanical Thrombectomy Using Stent Retrievers in Acute Ischemic Stroke.
    Ganesalingam J; Pizzo E; Morris S; Sunderland T; Ames D; Lobotesis K
    Stroke; 2015 Sep; 46(9):2591-8. PubMed ID: 26251241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of mechanical thrombectomy plus tissue-type plasminogen activator compared with tissue-type plasminogen activator alone for acute ischemic stroke in France.
    Kaboré N; Marnat G; Rouanet F; Barreau X; Verpillot E; Menegon P; Maachi I; Berge J; Sibon I; Bénard A
    Rev Neurol (Paris); 2019 Apr; 175(4):252-260. PubMed ID: 30642680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness of Solitaire Stent Retriever Thrombectomy for Acute Ischemic Stroke: Results From the SWIFT-PRIME Trial (Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke).
    Shireman TI; Wang K; Saver JL; Goyal M; Bonafé A; Diener HC; Levy EI; Pereira VM; Albers GW; Cognard C; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Devlin TG; Lopes DK; Reddy VK; du Mesnil de Rochemont R; Jahan R; Vilain KA; House J; Lee JM; Cohen DJ;
    Stroke; 2017 Feb; 48(2):379-387. PubMed ID: 28028150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of stent-retriever thrombectomy in combination with IV t-PA compared with IV t-PA alone for acute ischemic stroke in the UK.
    Lobotesis K; Veltkamp R; Carpenter IH; Claxton LM; Saver JL; Hodgson R
    J Med Econ; 2016 Aug; 19(8):785-94. PubMed ID: 27046347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost-utility analysis of mechanical thrombectomy as an adjunct to intravenous tissue-type plasminogen activator for acute large-vessel ischemic stroke.
    Kim AS; Nguyen-Huynh M; Johnston SC
    Stroke; 2011 Jul; 42(7):2013-8. PubMed ID: 21636817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of mechanical thrombectomy with stent retriever in the treatment of acute ischemic stroke in Italy.
    Ruggeri M; Basile M; Zini A; Mangiafico S; Agostoni EC; Lobotesis K; Saver J; Coretti S; Drago C; Cicchetti A
    J Med Econ; 2018 Sep; 21(9):902-911. PubMed ID: 29882711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effectiveness of Thrombectomy in Patients With Acute Ischemic Stroke: The THRACE Randomized Controlled Trial.
    Achit H; Soudant M; Hosseini K; Bannay A; Epstein J; Bracard S; Guillemin F;
    Stroke; 2017 Oct; 48(10):2843-2847. PubMed ID: 28916667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of Intra-Arterial Treatment as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke.
    Leppert MH; Campbell JD; Simpson JR; Burke JF
    Stroke; 2015 Jul; 46(7):1870-6. PubMed ID: 26012639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs.
    Sandercock P; Berge E; Dennis M; Forbes J; Hand P; Kwan J; Lewis S; Lindley R; Neilson A; Wardlaw J
    Stroke; 2004 Jun; 35(6):1490-7. PubMed ID: 15105519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke: experience from Australian stroke center.
    Tan Tanny SP; Busija L; Liew D; Teo S; Davis SM; Yan B
    Stroke; 2013 Aug; 44(8):2269-74. PubMed ID: 23780955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of stent-retriever thrombectomy in large vessel occlusion strokes of the anterior circulation: Analysis from the French societal perspective.
    Barral M; Armoiry X; Boudour S; Aulagner G; Schott AM; Turjman F; Gory B; Viprey M
    Rev Neurol (Paris); 2020 Mar; 176(3):180-188. PubMed ID: 31526554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanical Thrombectomy in Patients With Acute Ischemic Stroke: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(4):1-79. PubMed ID: 27026799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of economic evaluations on stent-retriever thrombectomy for acute ischemic stroke.
    Boudour S; Barral M; Gory B; Giroudon C; Aulagner G; Schott AM; Turjman F; Viprey M; Armoiry X
    J Neurol; 2018 Jul; 265(7):1511-1520. PubMed ID: 29392462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term cost-effectiveness of thrombectomy for acute ischaemic stroke in real life: An analysis based on data from the Swedish Stroke Register (Riksstroke).
    Steen Carlsson K; Andsberg G; Petersson J; Norrving B
    Int J Stroke; 2017 Oct; 12(8):802-814. PubMed ID: 28375069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of endovascular thrombectomy in patients with acute ischemic stroke.
    Aronsson M; Persson J; Blomstrand C; Wester P; Levin LÅ
    Neurology; 2016 Mar; 86(11):1053-9. PubMed ID: 26873954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reimbursement for thrombectomy devices in patients who are ineligible for intravenous tissue-type plasminogen activator.
    Broderick JP; Tomsick TA;
    Stroke; 2013 May; 44(5):1215-6. PubMed ID: 23598521
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-Effectiveness of Endovascular Stroke Therapy: A Patient Subgroup Analysis From a US Healthcare Perspective.
    Kunz WG; Hunink MG; Sommer WH; Beyer SE; Meinel FG; Dorn F; Wirth S; Reiser MF; Ertl-Wagner B; Thierfelder KM
    Stroke; 2016 Nov; 47(11):2797-2804. PubMed ID: 27758942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-utility analysis of mechanical thrombectomy between 6 and 24 hours in acute ischemic stroke.
    Pizzo E; Dumba M; Lobotesis K
    Int J Stroke; 2020 Jan; 15(1):75-84. PubMed ID: 30758277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness of Tenecteplase Before Thrombectomy for Ischemic Stroke.
    Gao L; Moodie M; Mitchell PJ; Churilov L; Kleinig TJ; Yassi N; Yan B; Parsons MW; Donnan GA; Davis SM; Campbell BCV;
    Stroke; 2020 Dec; 51(12):3681-3689. PubMed ID: 33023423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-specific Cost Effectiveness of Using Intravenous Recombinant Tissue Plasminogen Activator for Treating Acute Ischemic Stroke.
    Joo H; Wang G; George MG
    Am J Prev Med; 2017 Dec; 53(6S2):S205-S212. PubMed ID: 29153122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.